Check out the companies making the biggest moves in premarket trading: Oracle — The database software company fell 3% as worries around the AI trade continue to drag the stock lower. Rothschild & Co Redburn initiated coverage of Oracle with a sell rating, saying the market is “materially” overestimating Oracle’s contracted cloud revenues. It sees a 40% drop ahead for the stock. Intel — Shares moved 2% higher following a Bloomberg report that Intel has approached Apple about investing in the chipmaker. Talks are in the early stages, the report said, citing sources. Transocean — The stock tumbled 15.7% after the offshore driller announced its plans to sell 125 million shares of the company at a price of $3.05, significantly lower than Wednesday’s close of $3.64. Opendoor Technologies — Trading firm Jane Street disclosed a 5.9% stake in the online real estate platform, sending shares 5% higher. The stock has surged more than 400% so far this year. Lithium Americas — The mining stock popped another 21%, putting it on pace to build on its massive 95.8% surge from the previous session. Lithium Americas ripped higher Wednesday as the Trump administration seeks to build an equity stake in the Canadian company. Jabil — The electronic manufacturing company slipped 4%, despite reporting an earnings and revenue beat for its fourth quarter. Jabil’s core earnings were $3.29 per share, versus the $2.92 FactSet consensus estimate. Revenue was $8.25 billion, coming in above the $7.95 billion expected from analysts. Stitch Fix — Shares tumbled 7%. The online styling company reported lower adjusted EBITDA in the fourth fiscal quarter compared with the same period a year ago. Stitch Fix also said its active client base shrunk nearly 8% year over year. Hertz Global Holdings — The car rental company’s subsidiary, The Hertz Corporation, has agreed to sell $375 million in exchangeable senior notes, due in 2030. The stock added 2.7%. UniQure — The biotech firm’s stock soared nearly 9% after a clinical trial found the company’s experimental gene therapy for Huntington’s slowed the progress of the neurodegenerative disease. CarMax — Shares plummeted 13% after the used car retailer reported disappointing quarterly results. CarMax posted earnings of 64 cents per share in the second quarter, far below the $1.04 earnings per share analysts polled by FactSet were anticipating. Revenue of $6.59 billion missed the $7.01 billion consensus estimate. Blackberry — Shares added 2.6% after the company’s second-quarter earnings topped expectations. Blackberry’s adjusted earnings were 4 cents a share, vs the 1 cent expected from analysts polled by FactSet. Revenue was $129.6 million, beating the $120.1 million consensus estimate. — CNBC’s Fred Imbert, Sarah Min and Alex Harring contributed reporting. (Learn the best 2026 strategies from inside the NYSE with Josh Brown and others at CNBC PRO Live. Tickets and info here .)
